Hematopoietic stem cell and multilineage defects generated by constitutive β-catenin activation

Nature Immunology

Volumn 7, Issue 10, 2006, Pages 1037-1047

  Scheller, Marina ^a   Huelsken, Joerg ^b   Rosenbauer, Frank ^a   Taketo, Makoto M ^c   Birchmeier, Walter ^a,d   Tenen, Daniel G ^e   Leutz, Achim ^a,d  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b EPFL   (Switzerland)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HUMBOLDT UNIVERSITY   (Germany)

^e HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL ASSAY; CELL CYCLE PROGRESSION; CELL DAMAGE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DEATH; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; B-LYMPHOCYTES; BETA CATENIN; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; ERYTHROID CELLS; GRANULOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MEGAKARYOCYTES; MICE; MICE, MUTANT STRAINS; T-LYMPHOCYTES; WNT PROTEINS;

EID: 33748859509     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1387     Document Type: Article

References (59)

1. Morrison, S.J. & Weissman, I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661-673 (1994).
2. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005).
3. Staal, F.J. & Clevers, H.C. WNT signalling and haematopoiesis: A WNT-WNT situation. Nat. Rev. Immunol. 5, 21-30 (2005).
4. Huelsken, J. & Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11, 547-553 (2001).
5. Willert, K. & Nusse, R. Beta-catenin: A key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8, 95-102 (1998).
6. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804 (1997).
7. Behrens, J. et al. Functional interaction of an axin homolog, conductin, with b-catenin, APC, and GSK3b. Science 280, 596-599 (1998).
8. Siegfried, E., Chou, T.B. & Perrimon, N. wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate. Cell 71, 1167-1179 (1992).
9. Wodarz, A. & Nusse, R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14, 59-88 (1998).
10. Tamai, K. et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 407, 530-535 (2000).
11. Behrens, J. et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996).
12. Eastman, Q. & Grosschedl, R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr. Opin. Cell Biol. 11, 233-240 (1999).
13. Morin, P.J. & Weeraratna, A.T. Wnt signaling in human cancer. Cancer Treat. Res. 115, 169-187 (2003).
14. Taketo, M.M. Shutting down Wnt signal-activated cancer. Nat. Genet. 36, 320-322 (2004).
15. Giles, R.H., van Es, J.H. & Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1-24 (2003).
16. Moon, R.T., Kohn, A.D., De Ferrari, G.V. & Kaykas, A. WNT and β-catenin signalling: Diseases and therapies. Nat. Rev. Genet. 5, 691-701 (2004).
17. Rattis, F.M., Voermans, C. & Reya, T. Wnt signaling in the stem cell niche. Curr. Opin. Hematol. 11, 88-94 (2004).
18. Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409-414 (2003).
19. Austin, T.W., Solar, G.P., Ziegler, F.C., Liem, L. & Matthews, W. A role for the Wnt gene family in hematopoiesis: Expansion of multilineage progenitor cells. Blood 89, 3624-3635 (1997).
20. Van Den Berg, D.J., Sharma, A.K., Bruno, E. & Hoffman, R. Role of members of the Wnt gene family in human hematopoiesis. Blood 92, 3189-3202 (1998).
21. Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448-452 (2003).
22. Cobas, M. β-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 199, 221-229 (2004).
23. Xu, Y., Banerjee, D., Huelsken, J., Birchmeier, W. & Sen, J.M. Deletion of β-catenin impairs T cell development. Nat. Immunol. 4, 1177-1182 (2003).
24. Verbeek, S. et al. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374, 70-74 (1995).
25. Okamura, R.M. et al. Redundant regulation of T cell differentiation and TCRα gene expression by the transcription factors LEF-1 and TCF-1. Immunity 8, 11-20 (1998).
26. Reya, T. et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13, 15-24 (2000).
27. Jamieson, C.H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657-667 (2004).
28. Harada, N. et al. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18, 5931-5942 (1999).
29. Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427-1429 (1995).
30. + stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15, 659-669 (2001).
31. Christensen, J.L. & Weissman, I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98, 14541-14546 (2001).
32. Almeida, M., Han, L., Bellido, T., Manolagas, S.C. & Kousteni, S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/ AKT. J. Biol. Chem. 280, 41342-41351 (2005).
33. Kim, K., Pang, K.M., Evans, M. & Hay, E.D. Overexpression of β-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11, 3509-3523 (2000).
34. Cheng, T. et al. Hematopoietic stem cell quiescence maintained by 21cip1/ waf1. Science 287, 1804-1808 (2000).
35. Fleming, W.H., Alpern, E.J., Uchida, N., Ikuta, K., Spangrude, G.J. & Weissman, I.L. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell Biol. 122, 897-902 (1993).
36. - cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 96, 1380-1387 (2000).
37. Cheshier, S.H., Morrison, S.J., Liao, X. & Weissman, I.L. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 96, 3120-3125 (1999).
38. Lambert, J.F.S., Forget, B.G., Weissman, S.M. & Quesenberry, P.J. et al. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J. Exp. Med. 197, 1563-1572 (2003).
39. Na Nakorn, T., Traver, D., Weissman, I.L. & Akashi, K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109, 1579-1585 (2002).
40. Magli, M.C., Iscove, N.N. & Odartchenko, N. Transient nature of early haematopoietic spleen colonies. Nature 295, 527-529 (1982).
41. -/- mice due to decreased survival of early erythroblasts. Blood 98, 3261-3273 (2001).
42. Akashi, K., Traver, D., Miyamoto, T. & Weissman, I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193-197 (2000).
43. Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213-1225 (1991).
44. H-rearranged murine pre-B cell clones in vitro. Eur. J. Immunol. 21, 2895-2898 (1991).
45. Weissman, I., Spangrude, G., Heimfeld, S., Smith, L. & Uchida, N. Stem cells. Nature 353, 26 (1991).
46. + lympho-myeloid stem cells lacking erythromegakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295-306 (2005).
47. Zeng, H., Yucel, R., Kosan, C., Klein-Hitpass, L. & Moroy, T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J. 23, 4116-4125 (2004).
48. Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/ SCID mice on CXCR4. Science 283, 845-848 (1999).
49. Vermeulen, M. et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 92, 894-900 (1998).
50. Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G.V. & Wolf, N.S. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. USA 92, 9647-9651 (1995).
51. Feng, Z., Srivastava, A.S., Mishra, R. & Carrier, E. A regulatory role of Wnt signaling pathway in the hematopoietic differentiation of murine embryonic stem cells. Biochem. Biophys. Res. Commun. 324, 1333-1339 (2004).
52. Yoshida, T., Yao-Ming Ng, S., Zuniga-Pflucker, J.C. & Georgopoulos, K. Early hematopoietic lineage restrictions directed by Ikaros. Nat. Immunol. 7, 382-391 (2006).
53. Qiang, Y.W. & Rudikoff, S. Wnt signaling in B and T lymphocytes. Front. Biosci. 9, 1000-1010 (2004).
54. Domen, J., Cheshier, S.H. & Weissman, I.L. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191, 253-264 (2000).
55. Adams, J.M. et al. Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Harb. Symp. Quant. Biol. 64, 351-358 (1999).
56. Trowbridge, J.J., Xenocostas, A., Moon, R.T. & Bhatia, M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat. Med. 12, 89-98 (2006).
57. Murdoch, B. et al. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc. Natl. Acad. Sci. USA 100, 3422-3427 (2003).
58. Till, J.E. & Mc, C.E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222 (1961).
59. Passegue, E. Hematopoietic stem cells, leukemic stem cells and chronic myelogenous leukemia. Cell Cycle 4, 266-268 (2005).